NCT07320209

Brief Summary

This study aims to investigate how food cravings change when visual food cues are enriched with sound, smell, and interactive experiences in a virtual reality (VR) environment. A total of 34 healthy Marmara University students aged 18 and older will participate in the study between November 2025 and March 2026, with a possible extension until September 2026. Participants will be exposed to real, virtual, and multisensory food cues, and their food craving levels, saliva composition, blood glucose, EEG activity, and body temperature will be measured. Salivary alpha-amylase will be analysed as a biomarker of physiological arousal during food cue exposure. The study aims to compare how virtual food cues affect food craving and physiological responses compared to real food cues. Findings are expected to contribute to understanding eating behaviour, developing VR-based interventions for healthy nutrition, and encouraging interdisciplinary collaboration between nutrition and engineering fields.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Apr 2026Oct 2026

First Submitted

Initial submission to the registry

December 3, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 6, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2026

Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

5 months

First QC Date

December 3, 2025

Last Update Submit

April 27, 2026

Conditions

Keywords

Food cuehuman-computer interactionfood cravingsalivary compositionEEG

Outcome Measures

Primary Outcomes (3)

  • Change in EEG activation patterns in response to food cues

    Change in neural activation patterns measured by electroencephalography (EEG) in response to food cues presented in real-world and virtual reality environments. EEG data will be recorded using a 16-channel Brain Products LiveAmp system, assessing event-related potentials (P300, N200) and frequency band power (delta, theta, alpha, beta) across reward- and attention-related cortical regions.

    Baseline and peri-procedural (during exposure to food cues) within a single study session.

  • Food craving questionnaire score

    Assesses subjective food craving responses using the Food Cravings Questionnaire-State (FCQ-S). Total scores range from 15 to 75, with higher scores indicating greater momentary food craving intensity.

    Baseline and immediately after completion of all experimental cue conditions within a single study session.

  • Salivary α-amylase concentration (µU/mL)

    Salivary alpha-amylase concentration will be measured as an objective indicator of autonomic nervous system activation and physiological arousal in response to food cues presented in real-world and virtual reality environments.

    Baseline and peri-procedural (during exposure to food cues) within a single study session.

Secondary Outcomes (5)

  • Salivary flow rate (mL/min)

    Baseline and peri-procedural (during exposure to food cues) within a single study session.

  • Capillary blood glucose level (mg/dL)

    Measured pre-exposure and immediately post-exposure for each condition.

  • Subjective appetite rating score

    Baseline and immediately after completion of each experimental cue condition within a single study session.

  • Body surface temperature (°C)

    Baseline, during experimental cue exposure, and immediately post-exposure within a single study session.

  • Presence questionnaire score

    Immediately after completion of all virtual reality experimental conditions within a single study session.

Study Arms (1)

Healthy Volunteer Participants

EXPERIMENTAL

Participants will be exposed to real, virtual, and multisensory food cues, and their food craving levels, saliva composition, blood glucose, EEG activity, and body temperature will be measured. Salivary alpha-amylase will be analysed as a biomarker of physiological arousal during food cue exposure. University students aged 18 and older will participate in the study.

Behavioral: Real foodBehavioral: Virtual Reality Food

Interventions

Real foodBEHAVIORAL

Participants will be exposed to real foods and their food craving levels, saliva composition, blood glucose, EEG activity, and body temperature will be measured. Salivary alpha-amylase will be analysed as a biomarker of physiological arousal during food cue exposure.

Healthy Volunteer Participants

Participants will be exposed to vitrual foods and their food craving levels, saliva composition, blood glucose, EEG activity, and body temperature will be measured. Salivary alpha-amylase will be analyse

Healthy Volunteer Participants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being over 18 years of age.
  • Individuals with a normal Body Mass Index according to the WHO classification.
  • No known food allergies or eating disorder diagnoses.
  • Voluntarily agree to participate in the study and sign an informed consent form.
  • Be physically and psychologically suitable for virtual reality environment and electroencephalography (EEG) recording applications.

You may not qualify if:

  • History of any neurological disease (e.g., epilepsy, vertigo) that may prevent the use of virtual reality goggles
  • Allergy, intolerance, or sensitivity to foods used in the experimental procedure (e.g., chocolate biscuits, pickles)
  • Significant loss or impairment of vision, hearing, or sense of smell.
  • Sensitivity to the use of virtual reality devices (e.g. history of cyber sickness such as nausea, dizziness, etc.)
  • Use of psychiatric medication, antidepressants, neuroleptics, or medication that may affect neurological status
  • History of psychological conditions that may affect the working process, such as attention deficit, anxiety disorder, or panic attacks.
  • Any discomfort in the salivary glands, insufficient saliva production, or dry mouth.
  • Consumption of more than 21 units of alcohol per week (as this may affect food cravings and physiological parameters).
  • History or diagnosis of abnormal brain electrical activity that may affect EEG measurements.
  • History of substance dependence or any mental disorder that may affect cortical activity.
  • Conditions that prevent body composition analysis (BIA) measurements (e.g. use of a pacemaker, limb amputation, lymphoedema, etc.).
  • The presence of any language or cognitive barrier that prevents communication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University, Faculty of Health Sciences

Istanbul, Maltepe, 34854, Turkey (Türkiye)

RECRUITING

Central Study Contacts

Zehra M Çelik, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

December 3, 2025

First Posted

January 6, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

August 25, 2026

Study Completion (Estimated)

October 30, 2026

Last Updated

April 28, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) collected in this study will not be shared publicly. The data include sensitive physiological and neurocognitive measurements (EEG and salivary biomarkers) collected as part of a graduate thesis project. Data will be used solely for the purposes of the primary analyses described in the protocol and related scientific publications.

Locations